Alexis Desieno Sells 8,854 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 8,854 shares of the stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $32,494.18. Following the sale, the chief financial officer now owns 121,976 shares in the company, valued at $447,651.92. The trade was a 6.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Alexis Desieno also recently made the following trade(s):

• On Friday, November 15th, Alexis Desieno sold 25,118 shares of Cardlytics stock. The stock was sold at an average price of $3.43, for a total value of $86,154.74.

Cardlytics Stock Down 1.4 %

CDLX stock opened at $3.44 on Wednesday. The firm’s 50-day moving average is $3.90 and its two-hundred day moving average is $4.78. The company has a market capitalization of $174.83 million, a price-to-earnings ratio of -0.56 and a beta of 1.53. Cardlytics, Inc. has a 52 week low of $2.89 and a 52 week high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.18. The firm had revenue of $67.06 million for the quarter, compared to analysts’ expectations of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The firm’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.26) earnings per share. On average, analysts forecast that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CDLX has been the subject of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. Evercore ISI initiated coverage on shares of Cardlytics in a research note on Friday, October 11th. They set an “in-line” rating and a $4.00 target price for the company. Finally, Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average target price of $6.92.

Institutional Trading of Cardlytics

Several institutional investors have recently modified their holdings of CDLX. Check Capital Management Inc. CA grew its holdings in Cardlytics by 10.4% during the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock worth $162,000 after acquiring an additional 4,775 shares during the period. BNP Paribas Financial Markets grew its stake in shares of Cardlytics by 32.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after purchasing an additional 4,796 shares during the last quarter. Creative Planning raised its holdings in shares of Cardlytics by 35.4% in the 3rd quarter. Creative Planning now owns 29,537 shares of the company’s stock worth $95,000 after purchasing an additional 7,721 shares in the last quarter. Atom Investors LP acquired a new stake in Cardlytics during the third quarter valued at approximately $33,000. Finally, Quest Partners LLC boosted its holdings in Cardlytics by 160.4% during the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after buying an additional 11,061 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.